ArticleEuropean journal of applied physiology2026
Smoking quitting promotes neuromuscular and cartilage recovery in knee osteoarthritis.
Article in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesSmoking is known to exacerbate systemic inflammation and musculoskeletal decline, however, its reversible effects in osteoarthritis (OA) remain poorly understood. We evaluated whether smoking cessation improves disease severity, physical and respiratory function, and biochemical markers of neuromuscular junction (NMJ) integrity (C-terminal agrin-fragment-22; CAF22) and cartilage degradation (C-telopeptide of type II collagen; CTX-II) in patients with knee OA.
methodsThis one-year longitudinal study included 57 quitters and 61 active smokers with OA. Disease severity was classified using the Oxford Knee Score (OKS). Additional outcomes included WOMAC, handgrip strength (HGS), gait speed, maximal inspiratory and expiratory pressures (MIP and MEP, respectively), and plasma biomarkers of cartilage degradation (CTX-II) and NMJ disruption (CAF22). Standardized protocols and validated instruments were applied throughout.
resultsQuitters demonstrated significant improvements in OKS and WOMAC, along with increases in gait speed, HGS, and MIP compared to smokers (all p < 0.05). Disease severity distribution shifted favorably in quitters, with more patients moving from the severe to mild categories. In contrast, smokers showed worsening severity. In contrast to active smokers, quitters exhibited reduced CAF22 and CTX-II levels, suggesting an improved NMJ and cartilage integrity. Regression analyses confirmed strong associations between biomarker levels, disease severity, and functional outcomes.
conclusionsSmoking cessation was associated with improvements in disease severity, musculoskeletal and respiratory function, and biomarker profiles over one year. These findings suggest that cessation may contribute to a more favorable clinical trajectory in knee OA, although further studies are needed to confirm underlying mechanisms.
Indexed as
Identifiers
42189231What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.